Cluster 5 (Figure 6, purple cluster): The fifth part of the cluster study contains 10 high-frequency keywords such as bevacizumab, aflibercept, AMD, anti-VEGF therapy, tachyphylaxis, and so on. This evidence concerns the gene VEGFA and age-related macular degeneration.